Your browser doesn't support javascript.
loading
Phase 2 trial of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib.
Kumar, S K; LaPlant, B; Roy, V; Reeder, C B; Lacy, M Q; Gertz, M A; Laumann, K; Thompson, M A; Witzig, T E; Buadi, F K; Rivera, C E; Mikhael, J R; Bergsagel, P L; Kapoor, P; Hwa, L; Fonseca, R; Stewart, A K; Chanan-Khan, A; Rajkumar, S V; Dispenzieri, A.
Affiliation
  • Kumar SK; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • LaPlant B; Department of Biostatistics, Mayo Clinic, Rochester, MN, USA.
  • Roy V; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA.
  • Reeder CB; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA.
  • Lacy MQ; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Gertz MA; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Laumann K; Department of Biostatistics, Mayo Clinic, Rochester, MN, USA.
  • Thompson MA; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Witzig TE; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Buadi FK; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Rivera CE; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA.
  • Mikhael JR; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA.
  • Bergsagel PL; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA.
  • Kapoor P; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Hwa L; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Fonseca R; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA.
  • Stewart AK; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA.
  • Chanan-Khan A; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA.
  • Rajkumar SV; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Dispenzieri A; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Blood Cancer J ; 5: e338, 2015 Aug 14.
Article in En | MEDLINE | ID: mdl-26275080

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Boron Compounds / Glycine / Multiple Myeloma / Antineoplastic Agents Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Blood Cancer J Year: 2015 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Boron Compounds / Glycine / Multiple Myeloma / Antineoplastic Agents Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Blood Cancer J Year: 2015 Document type: Article Affiliation country: United States Country of publication: United States